Cowen And Company, LLC Athenex, Inc. Transaction History
Cowen And Company, LLC
- $3.88 Billion
- Q3 2024
A detailed history of Cowen And Company, LLC transactions in Athenex, Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 18,500 shares of ATNX stock, worth $185. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,500Holding current value
$185% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ATNX
# of Institutions
3Shares Held
1.46MCall Options Held
0Put Options Held
0About Athenex, Inc.
- Ticker ATNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 156,790,000
- Market Cap $1.57M
- Description
- Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...